HIV prevention on wheels: PrEP pills offered on mobile van for drug users

NCT ID NCT06908252

Completed Prevention Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study tests whether giving HIV prevention pills (PrEP) on a medical van is a good way to reach people who inject drugs and are at high risk for HIV. The researchers will enroll 20 adults who use drugs or are sexually active and see how many start and stay on PrEP. The goal is to see if this mobile approach helps prevent HIV in a hard-to-reach group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pre-Exposure Prophylaxis (PrEP) pills
What this could lead to: If this works, it could show that offering HIV prevention pills on a mobile medical van is an effective way to reach people who inject drugs and help prevent HIV.
What could go wrong: This is a very small early-stage study with only 20 participants, so results may not apply to larger groups. It focuses on feasibility, not on proving the pills prevent HIV.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTION

Contacts and locations

Locations

Duke Department of Population Health Sciences

Durham, North Carolina, 27701, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.